Status:
UNKNOWN
Polish Atrial Fibrillation (POL-AF) Registry
Lead Sponsor:
Jan Kochanowski University
Collaborating Sponsors:
Medical University of Warsaw
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of clinical characteristics and pharmacotherapy of hospitalized Polish patients with atrial fibrillation (AF).
Detailed Description
Atrial fibrillation (AF) is a common arrhythmia associated with increased cardiovascular mortality. An important element of management of patients with AF is anticoagulation to prevent thromboembolic ...
Eligibility Criteria
Inclusion
- \- patients with AF hospitalized in a participating center during study period
Exclusion
- hospitalisation for atrial fibrillation ablation
- death during hospitalization
Key Trial Info
Start Date :
January 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04419012
Start Date
January 6 2019
End Date
December 31 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iwona Gorczyca
Kielce, Poland, 25-525